Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy

<div>(a) Intersection of compound Xueshuantong capsule (CXC) targets (blue) and proliferative diabetic retinopathy (PDR) targets (yellow). (b) Intersection of Hexuemingmu tablet (HXMMT) targets (blue) and PDR targets (yellow). (c) Intersection of PDR-CXC targets (blue) and PDR-HXMMT targets (yellow).</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy 

Figure 3 | Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy 